Although the award was much deserved, it was for work done when Frazer was not associated with Admedus - so although it offers reassurance of a greater probability of success, it is super shifty for a company to leverage off a past achievement of a current (key) employee. The only thing that will change market sentiment is continual positive announcements of company progress, i.e. Cardiocel sales, revenue growth, medical sales profits and successful trial outcomes.
- Forums
- ASX - By Stock
- Vote for Ian!
Although the award was much deserved, it was for work done when...
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$12.00 |
Change
0.240(2.04%) |
Mkt cap ! $253.6M |
Open | High | Low | Value | Volume |
$11.98 | $12.00 | $11.51 | $97.20K | 8.235K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100 | $11.95 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.00 | 720 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100 | 11.950 |
1 | 150 | 11.710 |
1 | 150 | 11.700 |
1 | 29 | 11.600 |
1 | 52 | 11.510 |
Price($) | Vol. | No. |
---|---|---|
12.000 | 720 | 1 |
12.400 | 198 | 1 |
12.850 | 1000 | 1 |
13.000 | 4000 | 2 |
13.130 | 1000 | 1 |
Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |